Join to access to all OVN content. Join for Free

Results for 'Paul Ward'

How will COVID-19 affect the MSL role and what new skills may emerge as necessary to maintain value, access and future succes
Partner Avatar MSL Talk: Tom Caravela, Paul Ward
How will COVID-19 affect the MSL role and what new skills may emerge as necessary to maintain value, access and future succes

Paul Ward, Oncology MSLs, AstraZeneca, MSL Society, Covid-19 impact on MSLs

My guest today is Paul Ward. He is the National Director, Oncology MSLs at AstraZeneca, and MSL Society Advisory Board Member. We will discuss how Covid-19 will affect the role of the MSL and what new skills may emerge as necessary to maintain value, access, and future success. In this epi…

May 12th • 41 mins listen

Skip Level Meetings: Prepare, Purpose, Pitfalls
Partner Avatar MSL Talk: Tom Caravela, Paul Ward
Skip Level Meetings: Prepare, Purpose, Pitfalls

Skip Level Meetings, Medical Science Liaison, Paul Ward BeiGene, Medical Affairs Xcellence Summit, Momentum Events

In this episode, Paul Ward, head of field medical at BeiGene, joins Tom Caravela to delve into the concept of skip level meetings. Paul shares insights on who should initiate these meetings and their objectives, emphasizing the importance of effective communication. The discussion covers prepar…

Aug 23rd • 40 mins listen

How Medical Affairs Professionals Should Engage with Digital Opinion Leaders
Partner Avatar MSL Talk: Tom Caravela, Paul Ward
How Medical Affairs Professionals Should Engage with Digital Opinion Leaders

Digital Opinion Leaders, Medical Affairs, MSL Talk, Paul Ward, Tom Caravela, Medical Watch, AI in Medical Affairs, Digital Engagement, Online Misinformation, Scientific Credibility

In this episode of MSL Talk, Tom Caravela sits down with Paul Ward for an insightful conversation on the evolving role of Digital Opinion Leaders (DOLs) in Medical Affairs. Sponsored by Medical Watch, this episode explores why DOLs matter, how to identify the right ones, and what tools MSLs can use …

May 20th • 37 mins listen

Related Topics

Loading...